Wealth Enhancement Advisory Services’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.7M | Sell |
5,118
-9,286
| -64% | -$3.08M | ﹤0.01% | 1440 |
|
|
2025
Q1 | $3.89M | Buy |
14,404
+1,838
| +15% | +$496K | 0.01% | 915 |
|
|
2024
Q4 | $2.96M | Buy |
12,566
+6,112
| +95% | +$1.44M | 0.01% | 1001 |
|
|
2024
Q3 | $1.77M | Buy |
6,454
+2,323
| +56% | +$639K | ﹤0.01% | 1115 |
|
|
2024
Q2 | $1M | Buy |
4,131
+1,184
| +40% | +$288K | ﹤0.01% | 1274 |
|
|
2024
Q1 | $440K | Buy |
2,947
+548
| +23% | +$81.9K | ﹤0.01% | 1658 |
|
|
2023
Q4 | $459K | Buy |
2,399
+216
| +10% | +$41.3K | ﹤0.01% | 1555 |
|
|
2023
Q3 | $387K | Buy |
+2,183
| New | +$387K | ﹤0.01% | 1584 |
|
|
2020
Q3 | – | Sell |
-8,758
| Closed | -$1.38M | – | 205 |
|
|
2020
Q2 | $1.38M | Buy |
+8,758
| New | +$1.38M | 0.04% | 158 |
|